FW: Current Progress in CML Therapy - Webcast Announcement

[Guest guest]

The Webcast is now on line. I especially enoyed the Panel Discussion and

the Q & A session.

Zavie

Current Progress in CML Therapy - Webcast Announcement

<http://www.cancereducation.com/cancersyspagesnb/a/lls/lls0508/index_fwd

_aoi.cfm>

It is our pleasure to invite you to view an exciting Internet webcast

focused on chronic myelogenous leukemia (CML) titled:

<http://www.cancereducation.com/cancersyspagesnb/a/lls/lls0508/index_fwd

_aoi.cfm> Current Progress in CML Therapy: Outlook from a Panel of

Experts sponsored by The <http://www.lls.org/> Leukemia & Lymphoma

Society and supported by an unrestricted educational grant from Novartis

Oncology. This webcast is intended for patients, their families, and

health care professionals.

Internet Webcast Now Available!

.. View video presentations from experts

.. Listen to audio recordings, including a Question and Answer Session

.. Print written program transcripts

Click on the links below to view this webcast

Overview of CML and

<http://www.cancereducation.com/cancersyspagesnb/a/lls/lls0508/index_fwd

_aoi.cfm>

History of Treatment

Emerging Therapies

<http://www.cancereducation.com/cancersyspagesnb/a/lls/lls0508/index_fwd

_aoi.cfm>

Under Study

Current Status of Imatinib

<http://www.cancereducation.com/cancersyspagesnb/a/lls/lls0508/index_fwd

_aoi.cfm>

Therapy for CML

J. Druker, MD

Investigator

Medical Institute

JELD-WEN Chair of Leukemia Research

Oregon Health & Science University

Cancer Institute

Portland, OR

Cortes, MD

Internist

Professor of Medicine

Deputy Chair, Department of Leukemia

The University of Texas

MD Cancer Center

Houston , TX

W.N. Deininger, MD, PhD

Assistant Professor

Oregon Health & Science University

Center for Hematologic Malignancies

Portland, OR

For additional information on this program or other programs and

services offered by The Leukemia <http://www.lls.org> & Lymphoma

Society, please call the Society's Information Resource Center (IRC) at

(800) 955-4572. A certified professional will be available to answer any

questions you may have.

CONTINUING EDUCATION INFORMATION FOR NURSES

Approval for nurses has been obtained by The Leukemia

<http://www.lls.org> & Lymphoma Society's national office under

provider number CEP 5832 to award 2.0 continuing education contact hours

through the California Board of Registered Nurses; for social workers

under provider number 1105 to award 2.0 contact hours through the

Association of Social Work Boards. In order to receive credit for this

event, you will need to register and complete the evaluation under the

CE Credit - Health Care Professionals Only section of the webcast.

If you wish to remove your name from our list, please notify the

publishers at unsubscribe@.... Note: if your current

return e-mail address is different than the one you used to register,

you must provide us with the e-mail address that you used at the time

you registered.

<http://www.cancereducation.com/CancerSysImgs/lls/lls0508/LLS0508BlastFo

ot.gif>